Literature DB >> 23046277

Antimicrobial treatment concepts for orthopaedic device-related infection.

P Sendi1, W Zimmerli.   

Abstract

Successful management of orthopaedic device-related infections requires combined surgical and antimicrobial therapy. Because of the heterogeneity of clinical situations, controlled trials are lacking. Although rational concepts for surgical treatment have been published, many aspects of antimicrobial therapy are still not well documented. In this review, some of these knowledge gaps are discussed, and rational arguments for initial parenteral treatment are presented. In addition, the interpretation of data regarding bone penetration is discussed. Whereas rifampin is now a standard combination partner in the treatment of staphylococcal infections, its role against other microorganisms is still unclear. Finally, in view of the increasing prevalence of methicillin-resistant staphylococci and their decreasing susceptibility to vancomycin, data are provided on linezolid and daptomycin, which can potentially be used in bone and joint infections.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046277     DOI: 10.1111/1469-0691.12003

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  36 in total

Review 1.  [Orthopaedic implant-associated infections: Update of antimicrobial therapy].

Authors:  W Zimmerli
Journal:  Orthopade       Date:  2015-12       Impact factor: 1.087

2.  Short-interval two-stage approach to primary total knee arthroplasty for acutely septic osteoarthritic knees.

Authors:  Bettina Hochreiter; Carol Strahm; Henrik Behrend
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-01-14       Impact factor: 4.342

3.  CORR Insights®: What is the Accuracy of Nuclear Imaging in the Assessment of Periprosthetic Knee Infection? A Meta-analysis.

Authors:  Thomas Ilchmann
Journal:  Clin Orthop Relat Res       Date:  2017-02-02       Impact factor: 4.176

Review 4.  Prosthetic Joint Infections: an Update.

Authors:  C L Abad; A Haleem
Journal:  Curr Infect Dis Rep       Date:  2018-05-22       Impact factor: 3.725

Review 5.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

Review 6.  [Treatment of periprosthetic infections].

Authors:  L Renner; C Perka; A Trampuz; N Renz
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

7.  Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.

Authors:  S Tevell; C Claesson; B Hellmark; B Söderquist; Å Nilsdotter-Augustinsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-14       Impact factor: 3.267

8.  Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery.

Authors:  Cornelia B Landersdorfer; Martina Kinzig; Rainer Höhl; Peter Kempf; Roger L Nation; Fritz Sörgel
Journal:  ACS Pharmacol Transl Sci       Date:  2020-05-25

9.  Finegoldia magna Isolated from Orthopedic Joint Implant-Associated Infections.

Authors:  Bo Söderquist; Sanna Björklund; Bengt Hellmark; Anders Jensen; Holger Brüggemann
Journal:  J Clin Microbiol       Date:  2017-09-13       Impact factor: 5.948

10.  In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; King K Holmes; Matthew R Golden
Journal:  J Antimicrob Chemother       Date:  2014-01-26       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.